<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05115721</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-FY2021-59</org_study_id>
    <nct_id>NCT05115721</nct_id>
  </id_info>
  <brief_title>Establishing the Reference Interval for Pulse Oxygen Saturation in Neonates at High Altitude</brief_title>
  <official_title>A Prospective Study on Establishing the Reference Interval for Pulse Oxygen Saturation in Neonates at High Altitude</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Affiliated Hospital of Qinghai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qinghai Red Cross Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qinghai Women and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Geermu People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yushu Prefecture People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guoluo Tibetan Autonomous Prefecture People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The now widely used reference interval for pulse oxygen saturation of the neonate after 24&#xD;
      hours of birth has been developed relying on data from low altitude.It is not suitable for&#xD;
      neonates at high altitude. At present, no reference interval has been established at high&#xD;
      altitude, and the existing studies have many limitations. So this study was designed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Knowledge of the reference interval of pulse oxygen saturation (SpO2) in neonates is crucial&#xD;
      for accurate identification of neonatal hypoxemia. The now widely used standard was derived&#xD;
      from low altitude data, which is not suitable neonates at high altitude. At present, many&#xD;
      scholars have paid attention to this problem. But, previous studies still have some&#xD;
      limitations. For example, they often only focus on a specific altitude. However, with the&#xD;
      increase of altitude, the pulse oxygen saturation decreases in a curve, so their study&#xD;
      results are only suitable for this specific altitude and can not be widely used.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 25, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 25, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse oxygen saturation of healthy neonates at high altitude.</measure>
    <time_frame>24 hours after birth</time_frame>
    <description>Pulse oxygen saturation of the right hand and any foot of healthy neonates born at high altitude will be measured 24 hours after birth. According to the normality of the results, the distribution range will be described by mean ± standard deviation or range interquartile. Altitude level: ≥ 2000m.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>High Altitude</condition>
  <arm_group>
    <arm_group_label>Pre-ductal SpO2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-ductal SpO2</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>It's only observational study. No interventions.</description>
    <arm_group_label>Post-ductal SpO2</arm_group_label>
    <arm_group_label>Pre-ductal SpO2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutively delivered and eligible neonates at the various medical centers at&#xD;
        different altitudes during the study will be included. The study period is from November&#xD;
        20, 2021 to November 20, 2022.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy singleton term infants with no clinical signs and symptoms (e.g., cyanosis,&#xD;
             respiratory distress, heart murmur, etc.).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Low birth weight (&lt; 2500 g). 2. Need for oxygen. 3.1 or 5 minute Apgar score &lt; 7.&#xD;
             4. Referred to the neonatal intensive care unit or neonatology department for various&#xD;
             reasons. 5. Neonates discharged within 24 hours of birth. 6. Neonates diagnosed with&#xD;
             congenital diseases in utero. 7. Refusal of consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhangbin Yu, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhangbin Yu, PHD</last_name>
    <phone>+86-025-52226567</phone>
    <email>yuzhangbin@126.com</email>
  </overall_contact>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 30, 2021</study_first_submitted>
  <study_first_submitted_qc>November 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Zhangbin Yu</investigator_full_name>
    <investigator_title>Clinical Professor，The Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

